These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1238 related articles for article (PubMed ID: 32977835)

  • 1. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
    Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and antimicrobial resistance pattern of Clostridium difficile among hospitalized diarrheal patients: A systematic review and meta-analysis.
    Dilnessa T; Getaneh A; Hailu W; Moges F; Gelaw B
    PLoS One; 2022; 17(1):e0262597. PubMed ID: 35025959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance progression in the United Kingdom: A temporal comparison of Clostridioides difficile antimicrobial susceptibilities.
    Jon J V; Mark H W; Jane F
    Anaerobe; 2021 Aug; 70():102385. PubMed ID: 34048922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial resistance surveillance of Clostridioides difficile in Australia, 2015-18.
    Putsathit P; Hong S; George N; Hemphill C; Huntington PG; Korman TM; Kotsanas D; Lahra M; McDougall R; McGlinchey A; Moore CV; Nimmo GR; Prendergast L; Robson J; Waring L; Wehrhahn MC; Weldhagen GF; Wilson RM; Riley TV; Knight DR
    J Antimicrob Chemother; 2021 Jun; 76(7):1815-1821. PubMed ID: 33895826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spore-Forming
    Chisholm JM; Putsathit P; Riley TV; Lim SC
    Microbiol Spectr; 2023 Feb; 11(1):e0358222. PubMed ID: 36475924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
    Cheng JW; Liu C; Kudinha T; Xiao M; Fan X; Yang CX; Wei M; Liang GW; Shao DH; Xiong ZJ; Hou X; Yu SY; Wang Y; Yang QW; Su JR; Xu YC
    Int J Antimicrob Agents; 2020 Jul; 56(1):105981. PubMed ID: 32330584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology and antimicrobial susceptibility of human Clostridium difficile isolates from a single institution in Northern China.
    Wang B; Lv Z; Zhang P; Su J
    Medicine (Baltimore); 2018 Jun; 97(25):e11219. PubMed ID: 29924052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Binary Toxin Gene Detection and Decreased Susceptibility to Antibiotics among Clostridioides difficile Strains on Disease Severity: a Single-Center Study.
    Costa DVS; Pham NVS; Hays RA; Bolick DT; Goldbeck SM; Poulter MD; Hoang SC; Shin JH; Wu M; Warren CA
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0048922. PubMed ID: 35861541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study.
    Freeman J; Vernon J; Pilling S; Morris K; Nicolson S; Shearman S; Clark E; Palacios-Fabrega JA; Wilcox M;
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):169-177. PubMed ID: 31811507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides difficile from River Water.
    Cizek A; Masarikova M; Mares J; Brajerova M; Krutova M
    Microbiol Spectr; 2022 Aug; 10(4):e0080622. PubMed ID: 35950844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High in vitro activity of fidaxomicin against Clostridium difficile isolates from a university teaching hospital in China.
    Cheng JW; Yang QW; Xiao M; Yu SY; Zhou ML; Kudinha T; Kong F; Liao JW; Xu YC
    J Microbiol Immunol Infect; 2018 Jun; 51(3):411-416. PubMed ID: 28693926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016.
    Thorpe CM; McDermott LA; Tran MK; Chang J; Jenkins SG; Goldstein EJC; Patel R; Forbes BA; Johnson S; Gerding DN; Snydman DR
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31085514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial susceptibilities, resistance mechanisms and molecular characteristics of toxigenic Clostridioides difficile isolates in a large teaching hospital in Chongqing, China.
    Dang Z; Yang B; Xia P; Huang J; Liao J; Li Y; Tang S; Han Q; Luo S; Xia Y
    J Glob Antimicrob Resist; 2024 Sep; 38():198-204. PubMed ID: 39048055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clostridioides (Clostridium) difficile in adults with diarrhoea in Vietnam.
    Khun PA; Phi LD; Bui HTT; Collins DA; Riley TV
    Anaerobe; 2023 Jun; 81():102741. PubMed ID: 37244476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.
    Kolte B; Nübel U
    J Antimicrob Chemother; 2024 Jun; 79(6):1320-1328. PubMed ID: 38598696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
    Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
    Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial Susceptibilities of Clostridium difficile Isolates from 12 Asia-Pacific Countries in 2014 and 2015.
    Lew T; Putsathit P; Sohn KM; Wu Y; Ouchi K; Ishii Y; Tateda K; Riley TV; Collins DA
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32393487
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran.
    Alimolaei M; Rahimi HR; Ezatkhah M; Shamsaddini Bafti M; Afzali S
    J Glob Antimicrob Resist; 2019 Dec; 19():22-27. PubMed ID: 30825696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J; Vernon J; Pilling S; Morris K; Nicholson S; Shearman S; Longshaw C; Wilcox MH;
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing antibiotic resistance in Clostridioides difficile: A systematic review and meta-analysis.
    Saha S; Kapoor S; Tariq R; Schuetz AN; Tosh PK; Pardi DS; Khanna S
    Anaerobe; 2019 Aug; 58():35-46. PubMed ID: 31330183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.